Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $10.49 in the prior trading day, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) closed at $9.17, down -12.58%. In other words, the price has decreased by -$12.58 from its previous closing price. On the day, 1.02 million shares were traded. EYPT stock price reached its highest trading level at $10.56 during the session, while it also had its lowest trading level at $9.05.
Ratios:
Our goal is to gain a better understanding of EYPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.45 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
On January 22, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $35.JP Morgan initiated its Overweight rating on January 22, 2024, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 23 ’24 when ANTHONY P. ADAMIS bought 67,100 shares for $10.04 per share.
David R. Guyer bought 36,975 shares of EYPT for $329,817 on Oct 14 ’24. On Aug 20 ’24, another insider, DICICCO WENDY F, who serves as the Director of the company, bought 2,567 shares for $7.79 each. As a result, the insider paid 19,997 and bolstered with 9,967 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 625861696 and an Enterprise Value of 395178944. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.97 while its Price-to-Book (P/B) ratio in mrq is 2.24. Its current Enterprise Value per Revenue stands at 8.645 whereas that against EBITDA is -3.449.
Stock Price History:
Over the past 52 weeks, EYPT has reached a high of $30.99, while it has fallen to a 52-week low of $5.86. The 50-Day Moving Average of the stock is -5.82%, while the 200-Day Moving Average is calculated to be -34.28%.
Shares Statistics:
The stock has traded on average 722.03K shares per day over the past 3-months and 696320 shares per day over the last 10 days, according to various share statistics. A total of 49.04M shares are outstanding, with a floating share count of 48.73M. Insiders hold about 8.94% of the company’s shares, while institutions hold 104.20% stake in the company. Shares short for EYPT as of 1730332800 were 9680960 with a Short Ratio of 13.41, compared to 1727654400 on 8929577. Therefore, it implies a Short% of Shares Outstanding of 9680960 and a Short% of Float of 16.03.
